Impact of Videoconference Updates in Neonatal Intensive Care Unit on Parental Stress of Preterm Infants (VISIO-NEONAT)

Sponsor
Poitiers University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03438071
Collaborator
(none)
28
1
6.5
4.3

Study Details

Study Description

Brief Summary

The aim of the study is to test the effect of daily videoconference updates between parents of preterm newborns and health care providers which also offer them the possibility of seeing their child on the parental stress in a neonatal intensive care unit (NICU).

Condition or Disease Intervention/Treatment Phase
  • Other: Videoconferencing

Study Design

Study Type:
Observational
Actual Enrollment :
28 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Impact of Daily Videoconference Updates in Neonatal Intensive Care Unit on Parental Stress of Preterm Infants : a Pilot Study
Actual Study Start Date :
Feb 21, 2018
Actual Primary Completion Date :
Aug 18, 2018
Actual Study Completion Date :
Sep 7, 2018

Arms and Interventions

Arm Intervention/Treatment
Control group

Videoconference group

Other: Videoconferencing
Daily videoconference updates using Skype between parents of preterm infants hospitalized in NICU and the nurse taking care of their child, lasting 5 to 10 minutes, to check with her for the daily news and then see their child through the camera.

Outcome Measures

Primary Outcome Measures

  1. Level of stress of the mothers [From date of inclusion until the date of discharge, assessed up to 1 month]

    Mean score of the mothers of preterm infants hospitalized in NICU on the PSS-NICU (Parental Stressor Scale NICU), measured once a week during all the last of their child's hospitalization in the unit, in the 2 groups.

Secondary Outcome Measures

  1. Level of stress of the fathers [From date of inclusion until the date of discharge, assessed up to 1 month]

    Mean score of the fathers of preterm infants hospitalized in NICU on the PSS-NICU, measured once a week during all the last of their child's hospitalization in the unit, in the 2 groups.

  2. Parental stress evolution [From the date of inclusion until the date of discharge, assessed up to 1 month]

    Evolution of the PSS-NICU score of both parents between the inclusion in the study and the last evaluation before their child's discharge of the NICU, in the 2 groups.

  3. Post-partum depression rate of the mothers [Through study completion, an average of 2 months]

    Score of the mothers of preterm infants hospitalized in NICU on the EPDS (Edinburgh Post-natal Depression Scale), measured at the inclusion, at discharge and a month later, in the 2 groups.

  4. Quality of the relationship between the parents and their child [Through study completion, an average of 2 months]

    Mean score of both parents of preterm infants hospitalized in NICU on the PBQ (Post-partum Bonding Questionnaire), measured once a week during all the last of their child's hospitalization in the unit and a month after his discharge, in the 2 groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Parents with a preterm child born between 24 weeks and 34 weeks and 6 days of gestational age, hospitalized in our NICU during recrutment period

  • Which agreed participating to the study after having complete information about it and sign a consent.

Exclusion Criteria:
  • Parents with a preterm child with another pathology than prematurity or with a lenght of stay in the NICU less than 7 days

  • Parents refusing to participate to the study

  • Parents not having videoconference equipment or internet access at home

  • Parents not understanding or speaking good enough French.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU DE Poitiers Poitiers France

Sponsors and Collaborators

  • Poitiers University Hospital

Investigators

  • Principal Investigator: Denis Oriot, Poitiers University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Poitiers University Hospital
ClinicalTrials.gov Identifier:
NCT03438071
Other Study ID Numbers:
  • VISIO-NEONAT
First Posted:
Feb 19, 2018
Last Update Posted:
Jun 1, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2020